What is Next for the Genetics of Multiple Sclerosis?
| dc.contributor.author | Ramagopalan, Sreeram V. | |
| dc.contributor.author | Dyment, David A. | |
| dc.date.accessioned | 2018-09-27T11:59:23Z | |
| dc.date.available | 2018-09-27T11:59:23Z | |
| dc.date.issued | 2011-03-28 | |
| dc.date.updated | 2018-09-27T11:59:23Z | |
| dc.description.abstract | We review here our current understanding of the genetic aetiology of the common complex neurological disease multiple sclerosis (MS). The strongest genetic risk factor for MS is the major histocompatibility complex which was identified in the 1970s. In 2011, after a number of genome-wide association studies have been completed and have identified approximately 20 new genes for MS, we ask the question—what is next for the genetics of MS? | |
| dc.description.version | Peer Reviewed | |
| dc.identifier.citation | Sreeram V. Ramagopalan and David A. Dyment, “What is Next for the Genetics of Multiple Sclerosis?,” Autoimmune Diseases, vol. 2011, Article ID 519450, 3 pages, 2011. doi:10.4061/2011/519450 | |
| dc.identifier.doi | https://doi.org/10.4061/2011/519450 | |
| dc.identifier.uri | http://hdl.handle.net/1880/108420 | |
| dc.identifier.uri | https://doi.org/10.11575/PRISM/44371 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | Copyright © 2011 Sreeram V. Ramagopalan and David A. Dyment. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.title | What is Next for the Genetics of Multiple Sclerosis? | |
| dc.type | Journal Article |